INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago

Form 4 transactions

7,816 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
62
MP
Marino Glenn PDirector
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$393K
17.4K sh
Nov 2, 2026Nov 4, 2026
Page 1 of 196
Next →
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

59
LM
Langenstein MollyDirector
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$50K
2,186 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

55
WR
Wooters RebeccaEVP, Chief Growth Officer
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$99K
4,325 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

54
BJ
Brown Jeffrey JDirector
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$400K
17.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

54
KH
Khouri HalimEVP, Chief Financial Officer
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$251K
11.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

51
KB
Kumar BalajiEVP, Chief Technology Officer
UPBDUPBOUND GROUP, INC.
Open-market purchase
BUY$50K
2,200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

51
PA
Partners Group Finance (USD) AGAffiliate of the Adviser
NAPartners Group Growth, LLC
Open-market purchase
BUY$19.98M
9.51M sh
Nov 1, 2026Nov 4, 2026
traded Nov 1, 2026
+3dSEC FORM 4

Evidence

49
WL
Way T LawrenceDirector
CUBICustomers Bancorp, Inc.
Open-market sale
SELL$4.09M
48.8K sh
Oct 30, 2026Nov 4, 2026
traded Oct 30, 2026
+5dSEC FORM 4

Evidence

48
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$6.83M
7,073 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

47
SA
Shepherd Brian A.Director
LRNStride, Inc.
Open-market purchase
BUY$545K
7,120 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

47
SA
Shepherd Brian A.Director
LRNStride, Inc.
Open-market purchase
BUY$375K
4,880 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

45
MM
Manley Michael MarkDirector, CEO and Director
ANAUTONATION, INC.
Open-market purchase
BUY$682K
3,708 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

45
MM
Manley Michael MarkDirector, CEO and Director
ANAUTONATION, INC.
Open-market purchase
BUY$349K
1,892 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.47M
1,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.43M
2,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
ZF
Zuberbuhler Adolfo FernandoChief Financial Officer
PAMPampa Energy Inc.
Open-market purchase
BUY$207K
3,136 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC FORM 4

Evidence

44
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$3.80M
3,939 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$4.18M
4,338 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.58M
2,670 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

43
TF
Tamer FordDirector, President & CEO
LSCCLATTICE SEMICONDUCTOR CORP
Open-market purchase
BUY$585K
5,696 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC FORM 4

Evidence

43
TF
Tamer FordDirector, President & CEO
LSCCLATTICE SEMICONDUCTOR CORP
Open-market purchase
BUY$295K
2,894 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC FORM 4

Evidence

43
TE
Tryniski Mark EDirector
TBBKBancorp, Inc.
Open-market purchase
BUY—
5,000 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

42
MM
Murphy Robert MadisonDirector
MUSAMurphy USA Inc.
Open-market sale
SELL$589K
1,000 sh
May 4, 2026Nov 4, 2026
traded May 4, 2026
+184dSEC FORM 4

Evidence

42
SA
Szlosek Thomas AEVP & CFO
ANAUTONATION, INC.
Open-market purchase
BUY$100K
551 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

42
EC
Edmunds C ColemanEVP, Gen Counsel & Corp Sec
ANAUTONATION, INC.
Open-market purchase
BUY$55K
300 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

42
SM
Skeete Bernard MChief Accounting Officer
VLTOVeralto Corp
Open-market sale
SELL$170K
1,514 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

41
KE
Kowaleski John E.Director
GLOClough Global Opportunities Fund
Open-market purchase
BUY$1,997
365 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

41
KE
Kowaleski John E.Director
GLVClough Global Dividend & Income Fund
Open-market purchase
BUY$4,050
700 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

41
KE
Kowaleski John E.Director
GLQClough Global Equity Fund
Open-market purchase
BUY$1,966
260 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

40
PM
Pope Daniel MDirector
TYLTYLER TECHNOLOGIES INC
Open-market sale
SELL$277K
680 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
OS
Olschan Brian SDirector, President and COO
ACUACME UNITED CORP
Open-market sale
SELL$982K
14.2K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
WD
Wang Mark DDirector, See Remarks
HGVHilton Grand Vacations Inc.
Open-market purchase
BUY$499K
12.2K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.18M
1,224 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.01M
1,040 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

39
SA
Shepherd Brian A.Director
LRNStride, Inc.
Open-market purchase
BUY$372K
5,000 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

39
CC
Clay CraigSenior Advisor
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$1.89M
28.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

39
HR
Heyer Andrew RDirector
OSWONESPAWORLD HOLDINGS Ltd
Open-market sale
SELL$183K
7,000 sh
Aug 20, 2026Nov 4, 2026
traded Aug 20, 2026
+76dSEC FORM 4

Evidence

39
TJ
Treff Douglas JDirector
CROXCrocs, Inc.
Open-market sale
SELL$1.10M
7,185 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

39
SA
Shepherd Brian A.Director
LRNStride, Inc.
Open-market purchase
BUY$378K
5,000 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC FORM 4

Evidence

39
CC
Clay CraigSenior Advisor
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$1.45M
21.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Most active filers · 30d

  1. 01Kurtz George0B / 238S · 10 late238 trades$60.26M
  2. 02SPSaba Capital Management, L.P.53B / 19S · 3 late72 trades$21.23M
  3. 03CFCheng Chi Fung0B / 55S55 trades$21.42M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05NANithrakashyap Arvind0B / 35S35 trades$9.30M
  6. 06LBLeach Bryan0B / 33S33 trades$8.59M
  7. 07RJRubinstein Julie0B / 31S31 trades$5.54M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09BSBiswas Sanjit0B / 28S28 trades$22.33M
  10. 10RCRay Michael Charles0B / 28S28 trades$5.88M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. SELLIBEXIBEX LtdSep 8 – Sep 166 insiders$2.66M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 36 insiders$1.24M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K